Business Standard

Monday, December 23, 2024 | 05:40 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Nifty Pharma index surges 4%; Sun Pharma, Cipla hit 52-week highs

At 12:57 pm, Nifty Pharma index, the top gainer among sectoral indices, was up 4.2 per cent, as compared to 1.3 per cent gain in the benchmark Nifty50 index

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
Premium

In Union Budget 2021-22, Finance Minister Nirmala Sitharaman has increased allocation towards holistic health to Rs 2.23 trillion for FY22

SI Reporter Mumbai
Shares of pharmaceutical companies were in focus at the bourses on Wednesday, with the Nifty Pharma surging 4 per cent after a consolidating in the last couple of days.

Sun Pharmaceutical Industries and Cipla rallied 6 per cent each, hitting their respective 52-week highs on the National Stock Exchange (NSE) in intra-day trade. Torrent Pharmaceuticals and Dr Reddy’s Laboratories were up 5 per cent, while Divis Laboratories, Lupin, Cadila Healtchare and Biocon from the pharma index were up in the range of 3 per cent to 4 per cent.

At 12:57 pm, Nifty Pharma index, the top gainer

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in